Filing Flows › Lenz Therapeutics (LENZ) › License revenue revenue
Lenz Therapeutics (LENZ) License revenue revenue by quarter
Lenz Therapeutics' License revenue revenue was $785K in Q3 2026 (third quarter 2026), -79% from Q2 2026. Over the last 3 quarters it ranged from $250K (Q1 2026) to $3.8M (Q2 2026).
| Quarter | License revenue revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $785K | -79% | — |
| Q2 2026 | $3.8M | 15× | — |
| Q1 2026 | $250K | — | — |
Q3 2026 at a glance
Lenz Therapeutics, Q3 2026: revenue $3.4M (-73% year over year), operating margin -972.8%, net loss $31.0M, operating cash flow −$22.3M. The chart follows the revenue to costs, profit and cash.
Questions
What is Lenz Therapeutics' License revenue revenue?
Lenz Therapeutics' License revenue revenue was $785K in Q3 2026 (third quarter 2026), -79% from Q2 2026.
How has Lenz Therapeutics' License revenue revenue changed?
Over the last 3 quarters it ranged from $250K (Q1 2026) to $3.8M (Q2 2026).